Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07447908
Recruiting
Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor
Not applicable · Canada · 3 sites
Registry update: 6 Jul 2026
NCT07629817
Recruiting
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
Phase 3 · China · 1 site
Registry update: 31 Jul 2026
NCT07660055
Recruiting
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Phase 1 · Australia, Canada, Japan, United States · 5 sites
Registry update: 3 Nov 2026
NCT07502885
Recruiting
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Not applicable · United States · 1 site
Registry update: 18 Jun 2026
NCT07728123
Recruiting
Screen2Prevent (S2P)
Not applicable · United States · 5 sites
Registry update: 17 Aug 2026
NCT07823855
Recruiting
SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC
Not applicable · China · 1 site
Registry update: 16 Sept 2026
NCT07632339
Recruiting
Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 8 Jun 2026
NCT07733505
Recruiting
Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?
Phase 1 · Denmark · 1 site
Registry update: 29 Jul 2026
NCT07671417
Recruiting
Imaging Study in Metastatic Clear Cell RCC.
Early phase 1 · Australia, New Zealand, South Africa · 6 sites
Registry update: 13 Oct 2026
NCT07501780
Recruiting
Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice
Not applicable · Netherlands · 1 site
Registry update: 19 Oct 2026
NCT07647328
Recruiting
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Phase 3 · United Arab Emirates, Switzerland, Germany, Spain, France, Italy, South Korea, Poland, United States · 83 sites
Registry update: 19 Oct 2026
NCT07109375
Recruiting
Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
Not applicable · Italy · 7 sites
Registry update: 8 Jul 2026
NCT07436793
Recruiting
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Phase 2 · United States · 4 sites
Registry update: 2 Jul 2026
NCT07570589
Recruiting
Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)
Not applicable · France · 11 sites
Registry update: 1 Sept 2026
NCT07582042
Recruiting
Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
Not applicable · United States · 1 site
Registry update: 17 Jun 2026
NCT07660094
Recruiting
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
Phase 3 · United States · 1 site
Registry update: 22 Jun 2026
NCT07189325
Recruiting
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
Phase 3 · France · 27 sites
Registry update: 23 Jun 2026
NCT07416162
Recruiting
A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
Not applicable · South Korea · 2 sites
Registry update: 26 Jun 2026
NCT07707271
Recruiting
Continuous Versus High Intensity Interval Exercise in Chronic Obstructive Pulmonary Disease
Not applicable · Greece · 1 site
Registry update: 10 Sept 2026
NCT07588503
Recruiting
FES Cycling With BFR in the Spinal Cord Injury Population
Phase 1 · Canada · 1 site
Registry update: 14 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.